Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer

被引:3
|
作者
Czerwinski, Michal [1 ,2 ]
Bednarska-Czerwinska, Anna [2 ,3 ]
Zmarzly, Nikola [3 ]
Boron, Dariusz [3 ,4 ,5 ]
Oplawski, Marcin [4 ]
Grabarek, Beniamin Oskar [3 ,4 ,5 ]
机构
[1] Amer Med Clin, PL-40600 Katowice, Poland
[2] Gynctr Fertil Clin, PL-40121 Katowice, Poland
[3] Univ Technol Katowice, Fac Med, Dept Histol Cytophysiol & Embryol, PL-41800 Zabrze, Poland
[4] Ludwik Rydygier Mem Specialized Hosp, Dept Gynecol & Obstet Gynecol Oncol, PL-31826 Krakow, Poland
[5] TOMMED Specjalisci Zdrowia, Dept Gynecol & Obstet, Fredry 22, PL-40662 Katowice, Poland
关键词
endometrial cancer; biogenic amines; histamine receptors; dopamine receptors; expression profile; HISTAMINE-RECEPTOR ANTAGONISTS; H1; RECEPTOR; GROWTH-FACTOR; UP-REGULATION; DOPAMINE; CARCINOGENESIS; TRANSCRIPTION; BREAST; H3;
D O I
10.3390/jcm10214872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biogenic amines, such as adrenaline, noradrenaline, histamine, dopamine, and serotonin are important neurotransmitters that also regulate cell viability. Their detection and analysis are helpful in the diagnosis of many diseases, including cancer. The aim of this study was to determine the expression profile of the biogenic amine-related genes and proteins in endometrioid endometrial cancer compared to the control group. The material consisted of endometrial tissue samples and whole blood collected from 30 endometrioid endometrial cancer patients and 30 cancer-free patients. The gene expression was determined by the mRNA microarrays and validated by qRT-PCR. Protein levels were determined in the serum by the enzyme-linked immunosorbent assay (ELISA). Overexpression of histamine H1-H3 receptors and early growth response 1 and silencing of calmodulin, the histamine H4 receptor, and the dopamine D5 receptor have been reported in endometrioid endometrial cancer. The obtained results indicate disturbances in the signaling activated by histamine and dopamine receptors, which could potentially contribute to the progression of endometrioid endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Comparison of cyclin expression between endometrioid-type endometrial cancer (EEC) and endometrioid ovarian cancer (EOC).
    Nishimura, S
    Tsuda, H
    Hashiguchi, Y
    Garner, EIO
    Inoue, T
    Kawamura, N
    Mok, SC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 452S - 452S
  • [22] EXPRESSION OF MATRICELLULAR PROTEINS: TENASCIN C, SPARC AND THROMBOSPONDIN-1 IN ENDOMETRIOID ENDOMETRIAL CANCER - PRELIMINARY RESULTS
    Bogusiewicz, M.
    Semczuk, A.
    Miotla, P.
    Futyma, K.
    Nowakowski, L.
    Rechberger, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1056 - 1056
  • [23] Obesity is associated with altered angiogenic gene expression in endometrioid endometrial cancer
    Cobb, L. P.
    Siamakpour-Reihani, S.
    Zhang, D.
    Owzar, K.
    Berchuck, A.
    Bae-Jump, V. L.
    Secord, A. A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 177 - 178
  • [24] Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
    Kim, Mi-Kyung
    So, Kyeong A.
    Chun, Yi-Kyeong
    Kim, Yun Hwan
    Lim, Kyung Taek
    Lee, Ki Heon
    Kim, Tae Jin
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (05): : 724 - 728
  • [25] miRNAs in the Expression Regulation of Dopamine-Related Genes and Proteins in Endometrial Cancer
    Czerwinski, Michal
    Bednarska-Czerwinska, Anna
    Zmarzly, Nikola
    Boron, Dariusz
    Oplawski, Marcin
    Grabarek, Beniamin Oskar
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [26] β-catenin expression in endometrioid type endometrial cancer: Expression patterns and impact on disease outcomes
    Han, Orkun
    Alci, Aysun
    Yildirim, Hulya Tosun
    Gokkaya, Mustafa
    Yalcin, Necim
    Kandemir, Selim
    Goksu, Mehmet
    Ureyen, Isin
    Toptas, Tayfun
    ONCOLOGY LETTERS, 2024, 28 (06)
  • [27] LYMPH NODE METASTASIS AND THE RELATED FACTORS IN INTERMEDIATE RISK ENDOMETRIOID ENDOMETRIAL CANCER
    Feng, W.
    Zhu, M.
    Liu, X.
    Jia, N.
    Huang, F.
    Zhao, Y.
    Tao, X.
    Jiang, W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 981 - 981
  • [28] SELECTION OF HOUSEKEEPING GENES FOR MICRORNA EXPRESSION STUDIES IN ENDOMETRIOID ENDOMETRIAL CANCER TISSUES
    Torres, A.
    Torres, K.
    Wdowiak, P.
    Paszkowski, T.
    Maciejewski, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [29] Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival
    Segawa, T
    Shozu, M
    Murakami, K
    Kasai, T
    Shinohara, K
    Nomura, K
    Ohno, S
    Inoue, M
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2188 - 2194
  • [30] Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer
    Hartwich, Tobias Max Philipp
    Mansolf, Miranda
    Demirkiran, Cem
    Greenman, Michelle
    Bellone, Stefania
    McNamara, Blair
    Nandi, Shuvro P.
    Alexandrov, Ludmil B.
    Yang-Hartwich, Yang
    Coma, Silvia
    Pachter, Jonathan
    Santin, Alessandro D.
    CANCER MEDICINE, 2024, 13 (17):